METLIFE INC Quarterly Selling and Marketing Expense in USD from Q1 2017 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate total amount of expenses directly related to the marketing or selling of products or services.
Summary
Metlife Inc quarterly/annual Selling and Marketing Expense history and growth rate from Q1 2017 to Q2 2024.
  • Metlife Inc Selling and Marketing Expense for the quarter ending June 30, 2024 was $1.46B, a 1.04% increase year-over-year.
  • Metlife Inc Selling and Marketing Expense for the twelve months ending June 30, 2024 was $5.92B, a 7.68% increase year-over-year.
  • Metlife Inc annual Selling and Marketing Expense for 2023 was $5.82B, a 10.5% increase from 2022.
  • Metlife Inc annual Selling and Marketing Expense for 2022 was $5.27B, a 3.62% decline from 2021.
  • Metlife Inc annual Selling and Marketing Expense for 2021 was $5.46B, a 2.38% decline from 2020.
Selling and Marketing Expense, Trailing 12 Months (USD)
Selling and Marketing Expense, Quarterly (USD)
Selling and Marketing Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $5.92B $1.46B +$15M +1.04% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-01
Q1 2024 $5.91B $1.5B +$86M +6.07% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $5.82B $1.47B +$106M +7.76% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-16
Q3 2023 $5.71B $1.48B +$215M +17% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-02
Q2 2023 $5.5B $1.45B +$147M +11.3% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-01
Q1 2023 $5.35B $1.42B +$86M +6.46% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 $5.27B $1.37B +$50M +3.8% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-16
Q3 2022 $5.22B $1.27B -$55M -4.16% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 $5.27B $1.3B +$6M +0.46% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-04
Q1 2022 $5.26B $1.33B -$199M -13% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $5.46B $1.32B -$181M -12.1% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-16
Q3 2021 $5.64B $1.32B -$53M -3.85% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $5.7B $1.29B -$21M -1.6% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $5.72B $1.53B +$122M +8.67% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 $5.6B $1.5B -$71M -4.53% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-23
Q3 2020 $5.67B $1.38B -$138M -9.12% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 $5.81B $1.32B -$155M -10.5% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q1 2020 $5.96B $1.41B -$41M -2.83% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $6B $1.57B +$118M +8.14% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-18
Q3 2019 $5.88B $1.51B +$111M +7.91% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 $5.77B $1.47B +$32M +2.23% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-07
Q1 2019 $5.74B $1.45B +$33M +2.33% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
Q4 2018 $5.71B $1.45B +$66M +4.77% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-19
Q3 2018 $5.64B $1.4B +$10M +0.72% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-05
Q2 2018 $5.63B $1.44B +$132M +10.1% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-06
Q1 2018 $5.5B $1.42B +$112M +8.59% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q4 2017 $5.39B $1.38B Oct 1, 2017 Dec 31, 2017 10-K 2020-02-21
Q3 2017 $1.39B Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 $1.31B Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-07
Q1 2017 $1.3B Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.